SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 22, 2015

RX Safes, Inc.
(Exact name of registrant as specified in its charter)

 

Nevada   333-193800   27-2928918
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

170 Green Valley Parkway, Suite 300

Henderson, NV

 

 

89012

(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 516-983-9144

 

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

 

 
 

 

SECTION 5 – Corporate Governance and Management

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On June 22 2015, our Board of Directors appointed Mr. William Koch to serve as a member of the Board of Directors.

 

Mr. Koch, age 49 currently holds the position of Executive Vice President and Chief Sales and Marketing Officer at Tweddle Group, Inc. A Michigan based technical publications company known in the Automotive sector as an industry leading provider of both owners and service related vehicle documentation development, management and delivery. Prior to joining Tweddle Group over the last 4 1/2 years ago, he served as Vice President of Business Development at Pitney Bowes Marketing Solutions division where he lead sales and marketing activities in support of channel marketing and co-op advertising services supporting hundreds of fortune 500 companies and their distribution partners with their retail marketing strategies. Including the development of many pharmaceutical industry retail marketing programs for companies like McKesson, Novo Nordisk and Novartis to name a few.

 

Aside from that provided above, Mr. Koch does not hold and has not held over the past five years any other directorships in any company with a class of securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.

 

Mr. Koch is qualified to serve on our Board of Directors because of his experience and expertise in sales and marketing. His initial term shall last until the next annual meeting of the shareholders or until removed by other action as allowed by the corporate bylaws.

 

There were no arrangements or understandings between Mr. Koch and any other persons pursuant to which such individual was selected as a Director of our company.

 

Pursuant to our Director Compensation Policy, directors shall receive an initial option to purchase 250,000 shares of our common stock at a 50% discount to market that will vest immediately. Thereafter, directors are entitled to (a) a $10,000 annual cash retainer, payable in equal quarterly installments, (b) an annual grant of an option to purchase 250,000 shares of our common stock at a 50% discount to market that vests monthly and will fully vest in one year from issuance, and (c) $1,000 for each board meeting attended in person (or $500 if attended by teleconference) and additional compensation if serving as chairperson or committee participation. Directors have the option to take cash compensation in the form of our common stock at fair market value.

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

RX Safes, Inc.

 

/s/ Lorraine Yarde  
Lorraine Yarde  
CEO  
Date: June 24, 2015  

 

 

 

3